{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:19:47Z","timestamp":1792513187938,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T00:00:00Z","timestamp":1554422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12325-019-00941-6","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T16:49:45Z","timestamp":1554482985000},"page":"1426-1437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded \u201cDouble-Trouble\u201d Lipid Profile in Overweight\/Obese"],"prefix":"10.1007","volume":"36","author":[{"given":"Francesco","family":"Spannella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Giulietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Di Pentima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5159-0181","authenticated-orcid":false,"given":"Riccardo","family":"Sarzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,5]]},"reference":[{"issue":"9","key":"941_CR1","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2013.184182","volume":"310","author":"CK Chow","year":"2013","unstructured":"Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959\u201368.","journal-title":"JAMA"},{"key":"941_CR2","doi-asserted-by":"crossref","unstructured":"Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38 (32):2459-2472.","DOI":"10.1093\/eurheartj\/ehx144"},{"issue":"6","key":"941_CR3","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.HYP.0000165672.69176.ed","volume":"45","author":"G Mancia","year":"2005","unstructured":"Mancia G, Facchetti R, Bombelli M, et al. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension. 2005;45(6):1072\u20137.","journal-title":"Hypertension"},{"issue":"8","key":"941_CR4","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.mayocp.2017.02.018","volume":"92","author":"EA Bakker","year":"2017","unstructured":"Bakker EA, Lee DC, Sui X, et al. Association of resistance exercise, independent of and combined with aerobic exercise, with the incidence of metabolic syndrome. Mayo Clin Proc. 2017;92(8):1214\u201322.","journal-title":"Mayo Clin Proc."},{"issue":"4","key":"941_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.mayocp.2017.11.024","volume":"93","author":"EA Bakker","year":"2018","unstructured":"Bakker EA, Lee DC, Sui X, et al. Association of resistance exercise with the incidence of hypercholesterolemia in men. Mayo Clin Proc. 2018;93(4):419\u201328.","journal-title":"Mayo Clin Proc."},{"issue":"1","key":"941_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pcad.2017.02.006","volume":"60","author":"X Sui","year":"2017","unstructured":"Sui X, Sarzynski MA, Lee DC, et al. Impact of changes in cardiorespiratory fitness on hypertension, dyslipidemia and survival: an overview of the epidemiological evidence. Prog Cardiovasc Dis. 2017;60(1):56\u201366.","journal-title":"Prog Cardiovasc Dis."},{"issue":"3","key":"941_CR7","first-page":"432","volume":"94","author":"Y Wu","year":"2019","unstructured":"Wu Y, Johnson BT, Acabchuk RL, et al. Yoga as antihypertensive lifestyle therapy: a systematic review and meta-analysis. Mayo Clin Proc. 2019;94(3):432\u201346.","journal-title":"Mayo Clin Proc."},{"key":"941_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jacc.2014.02.615","volume":"64","author":"SM Boekholdt","year":"2014","unstructured":"Boekholdt SM, Hovingh GK, Mora S, et al. Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. J Am Coll Cardiol. 2014;64:485\u201394.","journal-title":"J Am Coll Cardiol"},{"key":"941_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"PS Sever","year":"2003","unstructured":"Sever PS, Dahl\u00f6f B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149\u201358.","journal-title":"Lancet"},{"issue":"7","key":"941_CR10","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/HJH.0000000000001730","volume":"36","author":"V Kotsis","year":"2018","unstructured":"Kotsis V, Jordan J, Micic D, et al. Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment. J Hypertens. 2018;36(7):1427\u201340.","journal-title":"J Hypertens"},{"issue":"2","key":"941_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40292-014-0054-3","volume":"21","author":"R Sarzani","year":"2014","unstructured":"Sarzani R, Bordicchia M, Spannella F, et al. Hypertensive heart disease and obesity: a complex interaction between hemodynamic and not hemodynamic factors. High Blood Press Cardiovasc Prev. 2014;21(2):81\u20137.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"2","key":"941_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/jch.12463","volume":"17","author":"M Fedecostante","year":"2015","unstructured":"Fedecostante M, Spannella F, Giulietti F, et al. Associations between body mass index, ambulatory blood pressure findings, and changes in cardiac structure: relevance of pulse and nighttime pressures. J Clin Hypertens (Greenwich). 2015;17(2):147\u201353.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"9","key":"941_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/oby.2000.79","volume":"8","author":"CD Brown","year":"2000","unstructured":"Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 2000;8(9):605\u201319.","journal-title":"Obes Res"},{"issue":"1","key":"941_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3810\/pgm.2014.01.2726","volume":"126","author":"I Chopra","year":"2014","unstructured":"Chopra I, Kamal KM, Candrilli SD, et al. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia. Postgrad Med. 2014;126(1):66\u201377.","journal-title":"Postgrad Med"},{"issue":"29","key":"941_CR15","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315\u201381.","journal-title":"Eur Heart J"},{"key":"941_CR16","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, et al. 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999\u20133058.","journal-title":"Eur Heart J"},{"issue":"17","key":"941_CR17","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1093\/eurheartj\/ehr080","volume":"32","author":"JR Banegas","year":"2011","unstructured":"Banegas JR, L\u00f3pez-Garc\u00eda E, Dallongeville J, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J. 2011;32(17):2143\u201352.","journal-title":"Eur Heart J"},{"key":"941_CR18","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1001\/jama.2013.280532","volume":"310","author":"SS Martin","year":"2013","unstructured":"Martin SS, Blaha MJ, Elshazly MB, et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013;310:2061\u20138.","journal-title":"JAMA"},{"key":"941_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/MBP.0000000000000135","volume":"20","author":"S Omboni","year":"2015","unstructured":"Omboni S, Palatini P, Parati G. Working Group on Blood Pressure Monitoring of the Italian Society of Hypertension. Standards for ambulatory blood pressure monitoring clinical reporting in daily practice: recommendations from the Italian Society of Hypertension. Blood Press Monit. 2015; 20: 241\u2013244.","journal-title":"Blood Press Monit"},{"issue":"10","key":"941_CR20","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953\u20132041.","journal-title":"J Hypertens"},{"key":"941_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","volume":"24","author":"RM Conroy","year":"2003","unstructured":"Conroy RM, Py\u00f6r\u00e4l\u00e4 K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987\u20131003.","journal-title":"Eur Heart J"},{"issue":"10","key":"941_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1177\/2047487315588390","volume":"23","author":"MT Cooney","year":"2016","unstructured":"Cooney MT, Selmer R, Lindman A, et al. Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol. 2016;23(10):1093-103.","journal-title":"Eur J Prev Cardiol"},{"issue":"17","key":"941_CR23","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735\u201352.","journal-title":"Circulation"},{"key":"941_CR24","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1161\/CIRCULATIONAHA.105.581934","volume":"112","author":"S Lewington","year":"2005","unstructured":"Lewington S, Clarke R. Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk. Circulation. 2005;112:3373\u20134.","journal-title":"Circulation"},{"issue":"4","key":"941_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/jhh.2016.71","volume":"31","author":"G Tocci","year":"2017","unstructured":"Tocci G, Nati G, Cricelli C, et al. Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database. J Hum Hypertens. 2017;31(4):258\u201362.","journal-title":"J Hum Hypertens"},{"key":"941_CR26","doi-asserted-by":"publisher","unstructured":"Spannella F, Filipponi A, Giulietti F, et al. Prognostic role of masked and white-coat hypertension: 10-Year mortality in treated elderly hypertensives. J Hum Hypertens. 2018. https:\/\/doi.org\/10.1038\/s41371-018-0140-4 . [Epub ahead of print].","DOI":"10.1038\/s41371-018-0140-4"},{"key":"941_CR27","doi-asserted-by":"crossref","unstructured":"Welch V, Tang SS. Treatment and control of BP and lipids in patients with hypertension and additional risk factors. Am J Cardiovasc Drugs. 2007;7(5): 381\u20139.","DOI":"10.2165\/00129784-200707050-00008"},{"issue":"1","key":"941_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.jhh.1002102","volume":"21","author":"M Martino Di","year":"2007","unstructured":"Di Martino M, Degli Esposti L, Filigheddu F, et al. Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice. J Hum Hypertens. 2007;21(1):53\u20139.","journal-title":"J Hum Hypertens"},{"key":"941_CR29","doi-asserted-by":"crossref","unstructured":"Foley TR, Singh GD, Kokkinidis DG, et al. High-Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease. J Am Heart Assoc. 2017;6(7):e005699.","DOI":"10.1161\/JAHA.117.005699"},{"issue":"4","key":"941_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.numecd.2010.06.009","volume":"22","author":"A Poli","year":"2012","unstructured":"Poli A, Tragni E, Casula M, et al. How many patients need statin treatment in a low-cardiovascular-risk country? Low-density lipoprotein-cholesterol target and distance from target distribution in an Italian cohort. Nutr Metab Cardiovasc Dis. 2012;22(4):327\u201336.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"941_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pcd.2013.10.007","volume":"8","author":"DL Whitford","year":"2014","unstructured":"Whitford DL, Al-Anjawi HA, Al-Baharna MM. Impact of clinical inertia on cardiovascular risk factors in patients with diabetes. Prim Care Diabetes. 2014;8(2):133\u20138.","journal-title":"Prim Care Diabetes"},{"issue":"5","key":"941_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575\u201384.","journal-title":"Can J Cardiol"},{"issue":"10","key":"941_CR33","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s12325-015-0252-y","volume":"32","author":"A Sierra de la","year":"2015","unstructured":"de la Sierra A, Pint\u00f3 X, Guijarro C, et al. Prevalence, treatment, and control of hypercholesterolemia in high cardiovascular risk patients: evidences from a systematic literature review in Spain. Adv Ther. 2015;32(10):944\u201361.","journal-title":"Adv Ther"},{"issue":"9","key":"941_CR34","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/jamacardio.2017.2293","volume":"2","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP. Low-density lipoprotein cholesterol treatment in the proprotein convertase subtilisin\/kexin type 9 inhibitor era: getting back on target. JAMA Cardiol. 2017;2(9):935\u20136.","journal-title":"JAMA Cardiol."},{"issue":"7","key":"941_CR35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/00004872-199816070-00008","volume":"16","author":"A Zanchetti","year":"1998","unstructured":"Zanchetti A, Bond MG, Hennig M, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 1998;16(7):949\u201361.","journal-title":"J Hypertens."},{"issue":"5","key":"941_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/HJH.0b013e3282f624a0","volume":"26","author":"R Sarzani","year":"2008","unstructured":"Sarzani R, Salvi F, Dess\u00ec-Fulgheri P, et al. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens. 2008;26(5):831\u201343.","journal-title":"J Hypertens."},{"key":"941_CR37","doi-asserted-by":"crossref","unstructured":"Sarzani R, Spannella F, Giulietti, et al. Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk. High Blood Press Cardiovasc Prev. 2017;24(2):115\u201326.","DOI":"10.1007\/s40292-017-0196-1"},{"issue":"6","key":"941_CR38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.numecd.2018.02.013","volume":"28","author":"F Spannella","year":"2018","unstructured":"Spannella F, Giulietti F, Cocci G, et al. N-terminal pro B-Type natriuretic peptide is inversely correlated with low density lipoprotein cholesterol in the very elderly. Nutr Metab Cardiovasc Dis. 2018;28(6):629\u201335.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"941_CR39","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/ATVBAHA.116.307601","volume":"36","author":"R Puri","year":"2016","unstructured":"Puri R, Nissen SE, Shao M, et al. Non-HDL cholesterol and triglycerides: implications for coronary atheroma progression and clinical events. Arterioscler Thromb Vasc Biol. 2016;36(11):2220\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"941_CR40","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1177\/2047487313494292","volume":"21","author":"B Eliasson","year":"2014","unstructured":"Eliasson B, Gudbj\u00f6rnsdottir S, Zethelius B, et al. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes. Eur J Prev Cardiol. 2014;21(11):1420\u20138.","journal-title":"Eur J Prev Cardiol"},{"issue":"19","key":"941_CR41","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.jacc.2016.08.038","volume":"68","author":"DT Ko","year":"2016","unstructured":"Ko DT, Alter DA, Guo H, et al. High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: the CANHEART study. J Am Coll Cardiol. 2016;68(19):2073\u201383.","journal-title":"J Am Coll Cardiol"},{"key":"941_CR42","doi-asserted-by":"crossref","unstructured":"Balietti P, Spannella F, Giulietti, et al. Ten-year changes in ambulatory blood pressure: the prognostic value of ambulatory pulse pressure. J Clin Hypertens (Greenwich). 2018; 20(9):1230\u201337.","DOI":"10.1111\/jch.13344"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00941-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-00941-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00941-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T10:36:02Z","timestamp":1663238162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-00941-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,5]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["941"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-00941-6","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,5]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}